These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [The ratio of blood platelet monoamineoxidase to aldehyde reductase activity in paranoid schizophrenia (author's transl)]. Landowski J; Wontrobski Z Psychiatr Pol; 1981; 15(2):133-7. PubMed ID: 7312994 [No Abstract] [Full Text] [Related]
9. The effect of vigabatrin on brain and platelet GABA-transaminase activities. Bolton JB; Rimmer E; Williams J; Richens A Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):35S-42S. PubMed ID: 2757907 [TBL] [Abstract][Full Text] [Related]
10. Paranoid schizophrenia and platelet MAO activity. Baron M; Perlman R; Levitt M Am J Psychiatry; 1980 Nov; 137(11):1465-6. PubMed ID: 7435694 [No Abstract] [Full Text] [Related]
11. [Activity of blood platelet monoamine oxidase and the clinical picture of the paranoid syndrome]. Landowski J; Afeltowicz Z Psychiatr Pol; 1977; 11(6):625-32. PubMed ID: 611520 [No Abstract] [Full Text] [Related]
12. GABA-transaminase in brain and blood platelets: basic and clinical aspects. Sherif FM Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1219-33. PubMed ID: 7863013 [TBL] [Abstract][Full Text] [Related]
13. Uptake of GABA and activity of GABA transaminase in blood platelets from children with absence epilepsy. Rainesalo S; Eriksson K; Saransaari P; Keränen T Neurochem Res; 2004 Oct; 29(10):1873-7. PubMed ID: 15532543 [TBL] [Abstract][Full Text] [Related]
14. Are paranoid schizophrenics biologically different from other schizophrenics? Potkin SG; Cannon HE; Murphy DL; Wyatt RJ N Engl J Med; 1978 Jan; 298(2):61-6. PubMed ID: 619236 [TBL] [Abstract][Full Text] [Related]